Striated muscle activator of rho signalling (STARS) is reduced in ageing human skeletal muscle and targeted by mir-628-5p by Russell, Andrew et al.
Striated muscle activator of Rho signalling (STARS) is
reduced in ageing human skeletal muscle and targeted by
miR-628-5p
A. P. Russell, M. A. Wallace, M. Kalanon, E. Zacharewicz, P. A. Della Gatta, A. Garnham and
S. Lamon
Institute for Physical Activity and Nutrition (IPAN), School of Exercise and Nutrition Sciences, Deakin University, Geelong, Vic.,
Australia
Received 11 August 2016,
revision requested 12 September
2016,
revision received 10 October
2016,
accepted 11 October 2016
Correspondence: A. P. Russell,
PhD, Institute for Physical Activity
and Nutrition (IPAN), School of
Exercise and Nutrition Sciences,
Deakin University, Burwood, Vic.
3125, Australia.
E-mail: aaron.russell@deakin.edu.
au
Abstract
Aim: The striated muscle activator of Rho signalling (STARS) is a muscle-
specific actin-binding protein. The STARS signalling pathway is activated
by resistance exercise and is anticipated to play a role in signal mechan-
otransduction. Animal studies have reported a negative regulation of
STARS signalling with age, but such regulation has not been investigated
in humans.
Methods: Ten young (18–30 years) and 10 older (60–75 years) subjects
completed an acute bout of resistance exercise. Gene and protein expres-
sion of members of the STARS signalling pathway and miRNA expression
of a subset of miRNAs, predicted or known to target members of STARS
signalling pathway, were measured in muscle biopsies collected pre-exer-
cise and 2 h post-exercise.
Results: For the first time, we report a significant downregulation of the
STARS protein in older subjects. However, there was no effect of age on
the magnitude of STARS activation in response to an acute bout of exer-
cise. Finally, we established that miR-628-5p, a miRNA regulated by age
and exercise, binds to the STARS 3’UTR to directly downregulate its tran-
scription.
Conclusion: This study describes for the first time the resistance exercise-
induced regulation of STARS signalling in skeletal muscle from older
humans and identifies a new miRNA involved in the transcriptional con-
trol of STARS.
Keywords ageing, exercise, microRNA, skeletal muscle, striated muscle
activator of Rho signalling.
Ageing is characterized by a gradual increase in cellu-
lar damage and a decline in physical function over
time. At the molecular level, multiple pathways are
dysregulated with ageing, contributing to the arrest of
cell growth and repair (Smith-Vikos & Slack 2012).
In mammals, ageing is associated with a decline in
skeletal muscle mass and function, referred to as sar-
copaenia. It is estimated that human adults lose about
10% of their muscle mass by the age of 50, with a
further average reduction of 1% per year until death
(Dorrens & Rennie 2003, Phillips 2012). Age-related
muscle atrophy is linked to a disruption in skeletal
muscle protein turnover (Boirie 2009) and reduced
regenerative capacity (Brack & Rando 2007). In addi-
tion, the elderly demonstrate impaired phosphoryla-
tion of several key proteins involved in skeletal muscle
protein synthesis following resistance exercise (Leger
et al. 2008, Kumar et al. 2009, Zacharewicz et al.
2014). This phenomenon is referred to as anabolic
resistance. Ageing is also associated with impaired
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Notch, Wnt (Arthur & Cooley 2012) and myogenic
regulatory factor (MRF) (Marsh et al. 1997, Dedkov
et al. 2003) signalling. These pathways are important
for efficient myogenesis (Corbu et al. 2010, Walker
et al. 2012) and their downregulation is believed to
contribute to inefficient muscle repair and function
with age (Shadrach & Wagers 2011). The molecular
mechanisms leading to age-related muscle wasting are
complex, and our understanding is far from complete.
Continued research is required to identify other sig-
nalling pathways that are important for the mainte-
nance of muscle size and function and are perturbed
in ageing human muscle.
The striated muscle activator of Rho signalling
(STARS) protein is an actin-binding protein highly
expressed in cardiac, smooth and skeletal muscle (Arai
et al. 2002, Mahadeva et al. 2002, Peng et al. 2008,
Troidl et al. 2009). STARS increases actin polymeriza-
tion, resulting in the nuclear translocation of the serum
response factor (SRF) transcriptional co-activator myo-
cardin-related transcription factor-A (MRTF-A; also
known as megakaryoblastic leukaemia 1 protein,
MKL1) (Arai et al. 2002, Kuwahara et al. 2005). This
signalling response enhances the activation of SRF
gene transcription, which plays a role in maintaining
skeletal muscle growth and repair (Olson & Nordheim
2010, Braun & Gautel 2011). STARS is also expressed
in the nucleus (Troidl et al. 2009, Wallace et al. 2011)
where it may interact directly with DNA to control
gene transcription (Zaleska et al. 2015). Stars gene
expression is decreased in skeletal muscle from aged
mice (Sakuma et al. 2008) and pigs (Peng et al. 2008)
when compared to young animals. The nuclear content
of MRTF-A, but not total SRF, is lower in skeletal
muscle of 24-month-old sarcopaenic mice when com-
pared with 3-month-old mice (Sakuma et al. 2008). At
present, it is unknown whether the STARS signalling
pathway is downregulated in skeletal muscle of older
compared with younger humans. Members of the
STARS signalling pathway increase following a single
bout of resistance exercise as well as training in young
healthy subjects (Lamon et al. 2009), suggesting that
they play a role in skeletal muscle adaptation and func-
tion. Molecular signalling responses to exercise are
often attenuated in older when compared to younger
muscle; however, whether this is the case for STARS
signalling has not been investigated.
Striated muscle activator of Rho signalling is a tran-
scriptional target of several transcription factors
including MyoD, ERRa, SRF and MEF2 (reviewed in
Wallace et al. 2012). The recent identification of
microRNAs (miRNAs) as additional regulators of
gene expression has added another level of complexity
in our understanding of transcriptional regulation.
miRNAs are now considered as essential regulators of
skeletal muscle health (reviewed in Zacharewicz et al.
2013). In human skeletal muscle, exercise and age reg-
ulate miRNA expression (Zacharewicz et al. 2013,
2014). miRNAs mainly act by degrading specific
mRNA species to prevent the resulting protein transla-
tion (Olsen & Ambros 1999, Lee et al. 2004b, Wight-
man et al. 2004, Humphreys et al. 2005, Pillai et al.
2005, Huili et al. 2010), and miRNA activity is lar-
gely dependent on its binding capacity to the target
mRNA molecule (Brennecke et al. 2005, Hu & Bruno
2011). While it has been established that miR-9 (Bul-
ler et al. 2012), miR-133a (Liu et al. 2008), miR-150
(Liu et al. 2015), miR-200 (Buller et al. 2012), miR-
320a (Chen et al. 2015) and miR-483-5p (Qiao et al.
2011) regulate SRF expression and miR-31 (Katsura
et al. 2016) and miR-206 (Zhang et al. 2015) regulate
MRTF-A expression, the miRNA regulation of STARS
is unknown.
The aims of this study were to, firstly, measure the
basal expression levels of STARS and members of its
signalling pathway in skeletal muscle from young and
older male subjects. Secondly, we compared the regu-
lation of STARS and members of its signalling path-
way in young and older human subjects following a
single bout of resistance exercise. Thirdly, we used a
high-throughput PCR-based miRNA array platform to
determine whether there was an effect of age and
exercise on the regulation of the miRNAs known to
target SRF and MRTF-A. Finally, we combined bioin-
formatics prediction modelling with luciferase reporter
technology to identify the potential miRNA regulation
of STARS.
Methods
Subjects
The subject characteristics and methodology have
been published previously (Stefanetti et al. 2014). Ten
young (18–30) and 10 older (60–75) healthy males
participated in the study. The study was approved by
the Deakin University Human Research Committee
(EC: 2011-043) in accordance to the Declaration of
Helsinki (2013) (http://www.wma.net/en/30publica-
tions/10policies/b3/). Informed consent and inclusion
and exclusion criteria have been described elsewhere
(Stefanetti et al. 2014).
Trial protocol
Dual-energy X-ray absorptiometry scan (DXA), pre-
liminary testing, exercise protocol and muscle biopsy
procedure have been described in the study by Ste-
fanetti et al. (2014). Briefly, the subjects completed an
acute bout of resistance exercise that consisted of
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three sets of 14 repetitions of leg extension exercise at
60% of maximal voluntary contraction (1 RM). Mus-
cle biopsies were collected immediately after exercise
and 2 h later.
Protein extraction and western blotting
Total protein was extracted using RIPA buffer (Milli-
pore, North Ryde, NSW, Australia) with 1 lL/mL pro-
tease inhibitor cocktail (Sigma-Aldrich, Castle Hill,
NSW, Australia) and 10 lL/mL Halt Phosphatase Inhi-
bitor Single-Use Cocktail (Thermo Scientific, Rockford,
IL, USA). Total protein content was determined using
the BCA Protein Assay Kit (Pierce Biotechnology,
Rockford, IL, USA) according to the manufacturer’s
instructions. Electrophoresis was performed using a 4–
12% NuPAGE Novex Bis-Tris Gel (Life Technologies,
Mulgrave, Vic., Australia) in NuPAGE SDS MOPS
Running Buffer (Life Technologies). Protein transfer
was performed onto PVDF membrane in a Bjerrum buf-
fer containing 50 mM Tris, 17 mM glycine and 10%
methanol. The membranes were blocked with 5% BSA
in PBS, after which they were incubated at 4 °C with
the following primary antibodies diluted 1:1000 in 5%
BSA in PBS: STARS (Institute of Medical and Veteri-
nary Science, Adelaide, SA, Australia); SRF (sc-335;
Santa Cruz, CA, USA); MRTF-A (sc-32909; Santa
Cruz); phospho-SRF-S103 (ab53130; Abcam, Cam-
bridge, MA, USA). Following overnight incubation, the
membranes were washed and incubated for 1 h with a
goat anti-rabbit IgG antibody labelled with an infrared-
fluorescent 800 nm dye (Alexa Fluor 800; Life Tech-
nologies) diluted 1:5000 in PBS containing 50%
Odyssey blocking buffer (LI-COR Biosciences, Lin-
coln, NE, USA) and 0.01% SDS. After washing, the
proteins were exposed on an Odyssey Infrared Imag-
ing System (LI-COR Biosciences) and individual protein
band optical densities were determined using the
Odyssey Infrared Imaging System software. All blots
were normalized against the GAPDH protein (G8795;
Sigma-Aldrich). C2C12 myotubes overexpressing ADV-
STARS (100 MOI) were used as a STARS-positive con-
trol (Wallace et al. 2016). C2C12 myoblasts (~70% con-
fluent) were treated for 1 h with phorbol ester 12-O-
tetradecanoylphorbol-13-acetate (TPA), also known as
12 myristate 13-acetate. TPA stimulates the serum
response element, providing a positive control for phos-
phorylated SRF (Gineitis & Treisman 2001).
RNA extraction and reverse transcription
RNA extraction and reverse transcription procedures
have been described in the study by Stefanetti et al.
(2014). miRNA reverse transcription has been
described in the study by Zacharewicz et al. (2014).
Real-time PCR
Real-time PCR was carried out using a Stratagene
MX3000 thermal cycler to measure mRNA levels.
mRNA levels of STARS, SRF, MRTF-A and PPIA
were measured using Brilliant Multiplex QPCR Mas-
ter Mix (Agilent Technologies, SantaClara, CA, USA)
and 5 ng of cDNA. Primer and probe details have
been published previously (Lamon et al. 2009). The
PCR conditions were 1 cycle of 10 min at 95 °C; 40
cycles of 30 s at 95 °C, 60 s at 60 °C. For PPIA, a
melting curve was included at the end of the PCR
cycles. To compensate for variations in input RNA
amounts and efficiency of the reverse transcription,
data were normalized to the PPIA (peptidylprolyl iso-
merase A, cyclophilin) gene. PPIA gene expression
levels were stable and did not differ between age, time
or a combination of both factors (Fig. S1). Ct values
were obtained from the MxPro qPCR software (Agi-
lent Technologies). Ct values were then logarithmi-
cally transformed and mean log-transformed Ct values
(referred to as arbitrary unit [AU] values) were consid-
ered for further analysis.
miRNA arrays and statistical analysis
miRNA expression in the samples was assessed using
the TaqMan Array Human MicroRNA A+B Cards
version Set v3.0 (Life Technologies) according to the
manufacturer’s instructions (Zacharewicz et al. 2014),
and the data were normalized using the global nor-
malization function. Statistical treatment of the data
(split plot ANOVA) has been comprehensively described
in the study by Zacharewicz et al. (2014).
Identification of miRNAs predicted to target the STARS
signalling pathway
The miRNAs predicted to target STARS were pre-
dicted on the basis of 3’UTR sequence homology
using miRWalk (Jin et al. 2009). The miRWalk soft-
ware enables the prediction of miRNA targets by
incorporating several known prediction software pro-
grams. miRanda, miRDB, miRWalk, RNA22 and Tar-
getscan were chosen within the miRWalk program. A
predicted mRNA/miRNA interaction was considered
significant when identified by a minimum of four pre-
diction software programs.
Luciferase reporter assay
HEK293 cells (ATCC, Manassas, VA, USA) (1–
2 9 105/mL) were seeded in black-walled 96-well
plates. Twenty-four hours after seeding, cells were
cotransfected with 150 ng pNanoglo2 vector
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(Promega, Alexandria, NSW, Australia) containing
either: no insertion (empty control); the full-length
human Stars 3’ UTR; the putative miR-628-5p STARS
target site (including the predicted seed site with 10
base pairs on either side); or its mutant control (pri-
mers listed in Table S1), cloned between SacI and
NheI downstream of the Nanoluc luciferase; together
with 5 nM miR-628-5p mimics (mirVanaTM miRNA
mimic; Life technologies), or an irrelevant miRNA
control (miR-99b-5p), using Lipofectamine 2000 (Life
technologies) following the manufacturer’s protocol.
Four or 6 h post-transfection, the media was removed
and replaced by normal media (DMEM with 10%
FBS). Twenty-four hours later, cells were consecu-
tively assayed for Firefly and Nanoluc luciferase
expression using the Nano-Glo Dual-luciferase
Reporter assay kit (Promega) following the manufac-
turer’s protocol.
Statistical methods
All data are reported as mean  SEM. After normal
distribution of the data and homogeneity of variance
established, analysis of variance (ANOVA) was used to
compare group means. Post hoc analysis was con-
ducted where appropriate using the least significant
difference (LSD) test. The significance levels were set
at P < 0.05.
Results
Subjects’ demographics
Subjects’ physiological characteristics have been
described elsewhere (Stefanetti et al. 2014).
Regulation of STARS, SRF and MRTF-A mRNA
expression with exercise and ageing
Resistance exercise increased STARS mRNA expres-
sion in young (10.3-fold) and older (6.7-fold) subjects
(main effect of exercise, P < 0.001) (Fig. 1a). Simi-
larly, SRF mRNA expression increased by 1.63-fold
and 1.3-fold in young and older subjects respectively
(main effect of exercise, P < 0.05) (Fig. 1b). There
was no significant age x exercise interaction. MRTF-A
mRNA levels did not vary with age or exercise
(Fig. 1c).
Regulation of STARS, SRF and MRTF-A protein
expression with exercise and ageing
Exercise had no effect on the protein levels of STARS,
MRTF-A, SRF and phospho-SRF measured in young
or older subjects 2 h post-exercise (Fig. 2). A
significant decrease in STARS protein expression was
observed in older subjects when compared to young
subjects (main effect of age, P < 0.01) (Fig. 2a). Phos-
pho-SRF protein levels were greater in older subjects
than in young subjects (main effect of age, P < 0.05)
(Fig. 2d). Age had no effect on MRTF-A or total SRF
protein expression (Fig. 2b,c).
Age and exercise regulation of miRNAs targeting
members of the STARS pathway
The miRNA array analysis returned a total of 26 miR-
NAs that were significant for one or more of the con-
trasts studied, indicating that the expression levels of
these miRNAs varied with age, exercise or a combina-
tion of both factors (previously reported in Zachare-
wicz et al. 2014). Of the miRNAs known to directly
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Figure 1 Striated muscle activator of Rho signalling
(STARS), serum response factor (SRF) and myocardin-related
transcription factor-A (MRTF-A) mRNA expression levels in
skeletal muscle from young and older subjects pre- and post-
exercise. *Main effect of exercise, P < 0.05. ‡Main effect of
exercise, P < 0.001.
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target SRF or MRTF-A, miR-320a and miR-483-5p
were regulated with age in our model (Fig. 3). No
change was observed for miR-9, miR-133a, miR-150
and miR-206 (Fig. S2), and miR-31 and miR-200
levels were expressed below the threshold for detec-
tion. Both miR-320a and miR-483-5p expression
levels were higher in older than in young subjects
(main effect of age, P < 0.01 and P < 0.001 respec-
tively) (Fig. 3a,c). A significant negative correlation
(P = 0.04; r = 0.37) was observed between Srf mRNA
and miR-483-5p, but not miR-320a, levels when all
subjects (pre- and post-exercise) were analysed
(Fig. 3b,d).
Identification of new miRNAs potentially targeting
STARS
As there has been no validation of a miRNA that reg-
ulates STARS, we performed a miRNA prediction
analysis using miRwalk on the subset of 26 miRNAs
that were significantly regulated in our model
(Zacharewicz et al. 2014). Of these, miR-520g-3p,
miR-539-5p and miR-628-5p were predicted to target
the human STARS transcript by four prediction soft-
ware programs included in the miRwalk software. Fig-
ure 4 displays the expression levels of miR-520g-3p,
miR-539-5p and miR-628-5p in young and older sub-
jects 2 h after exercise. MiR-520g-3p was significantly
reduced post-exercise in young subjects only
(P < 0.05) (Fig. 4a). There was a main effect of age
for miR-539-5p, which expression was greater in
older subjects (P < 0.05) (Fig. 4b). Finally, there was
a significant interaction effect for miR-628-5p expres-
sion levels (P < 0.05), which were reduced post-exer-
cise in young subjects and lower at rest in the older
subjects (P < 0.05 and P < 0.01 respectively)
(Fig. 4c).
Luciferase reporter assay
To confirm whether miR-628-5p, miR-520g-3p or
miR-539-5p was able to directly bind and regulate the
STARS 3’UTR, HEK293 cells were cotransfected with
a reporter plasmid containing the full-length STARS
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Figure 2 Striated muscle activator of Rho signalling (STARS), serum response factor (SRF) and myocardin-related transcription
factor-A (MRTF-A) and phospho-SRF protein expression levels in skeletal muscle from young and older subjects pre- and post-
exercise. Exercise had no effect on any of the proteins measured. *Main effect of age, P < 0.05. †Main effect of age, P < 0.01.
Note that the reported statistical significance of any comparisons is based on analyses of the transformed data, but the reported
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3’UTR as well as either a miR-628-5p, miR-520g-3p
or miR-539-5p mimic, an irrelevant miRNA that did
not have a predicted binding site on the STARS
3’UTR or no mimic at all. Twenty-four hours after
the cotransfection of the reporter plasmid and mimics,
there was 30% reduction in Nanoluc luciferase activ-
ity (P < 0.05) (Fig. 5a) in the cells containing the
miR-628-5p mimic when compared to cells transfected
with an irrelevant miRNA. When completing the
reporter assay using the miR-520g-3p or miR-539-5p
mimics, there was no reduction in the luminescence
levels demonstrating that these miRNAs did not bind
to the STARS 3’UTR (data not shown). We then
sought to investigate the miR-628-5p putative binding
site on the STARS 3’UTR. HEK293 cells were again
cotransfected with the miR-628-5p mimic or an irrele-
vant miRNA; however, this time we used a reporter
plasmid that contained a shorter version of the STARS
3’UTR. This shorter version contained only the puta-
tive miR-628-5p binding site as well as 10 base pairs
either side of the site. As an additional control, cells
were also transfected with this shorter STARS 3’UTR
reporter plasmid; however, the miR-628-5p binding
site was mutated. Twenty-four hours after the cotrans-
fection of reporter plasmid and the mimics, there was
a 32% reduction in Nanoluc luciferase activity
(P < 0.001) (Fig. 5b) in the cells containing the miR-
628-5p mimic when compared to cells transfected
with an irrelevant miRNA. No differences were
observed when the cells were transfected with the
STARS 3’UTR reporter containing the mutated miR-
628-5p binding site.
Discussion
The STARS signalling pathway plays an essential role
in skeletal muscle adaptation to mechanical stimuli
(Lamon et al. 2014). Previous studies have reported a
reduction in the mRNA and protein levels of members
of the STARS/SRF signalling axis with ageing, but the
effects of age on the regulation of the STARS pathway
in human skeletal muscle have not been investigated.
We report for the first time that STARS protein, but
not mRNA, levels are significantly decreased in human
skeletal muscle from older when compared to the
young subjects. A reduction in Stars gene expression
was previously reported in skeletal muscle from aged
mice (Sakuma et al. 2008) and pigs (Peng et al.
2008). This discrepancy between gene and protein
expression suggests the existence of alternative post-
transcriptional regulatory processes that may include
regulation via miRNAs. Although its function in skele-
tal muscle has not been fully elucidated, STARS is
anticipated to be necessary for muscle cell develop-
ment and repair. Overexpressing the STARS protein
in porcine smooth muscle cells and in the A10 rat
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vascular smooth muscle cell line (Ounzain et al. 2008)
enhanced proliferation and overexpressing STARS
accelerated C2C12 cell differentiation (Wallace et al.
2016). The elderly display a reduction in satellite cell
(myoblast) number and activation (Corbu et al. 2010,
Walker et al. 2012) leading to impaired regenerative
capacity. Reduced activity of STARS might therefore
contribute to the age-related muscle atrophy process
by impeding muscle cell regeneration in the elderly.
We did not observe an age-related decrease in SRF
mRNA or in the total and phosphorylated forms of
the SRF protein. Srf mRNA levels were also similar in
the gastrocnemius muscle of young (3 months) when
compared to old (15 month) mice (Lahoute et al.
2008). However, in whole muscle homogenates, total
SRF protein levels were reduced in old (Lahoute et al.
2008) and sarcopaenic (24 month) mice (Sakuma
et al. 2008) when compared with young mice. In con-
trast, analysis of the nuclear extracts following muscle
protein fractionation revealed that the protein levels
of the SRF transcriptional coactivator MRTF-A were
lower in sarcopaenic mice when compared with young
mice, with no difference in SRF (Sakuma et al. 2008).
Nuclear SRF represents the active, phosphorylated
form of SRF. Combined with our observed increase in
nuclear pSRF in human muscle from older subjects,
these results suggest that ageing skeletal muscle main-
tains its ability to regulate gene transcription via SRF.
The reason and mechanism for elevated basal levels of
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STARS 3’UTR is schematically represented above the graph.
‡Significantly different from irrelevant miR (P < 0.001).
Experiments were repeated three times using n = 6 wells per
group.
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phosphorylated SRF in muscle from older subjects is
not known. SRF is phosphorylated and activated by
numerous kinases, including, but not limited to, casein
kinase, CaM kinase IV and MAPKAP kinase 2
(Manak et al. 1990, Misra et al. 1991, Janknecht
et al. 1992, Marais et al. 1992, Heidenreich et al.
1999). In addition to MRTF-A, several factors co-acti-
vate SRF transcription, such as inositol polyphosphate
multikinase (IPMK) (Kim et al. 2013), Elk-1 (Jan-
knecht & Nordheim 1992), cardiogenic homeodomain
factor Nkx-2.5 (Chen & Schwartz 1996), SRF acces-
sory protein (SAP-1) (Dalton & Treisman 1992), p65/
NF-kappaB (Franzoso et al. 1996) and GATA binding
protein 4 (GATA-4) (Belaguli et al. 2000). In the
absence of MRTF-A, these other coactivators may
play a compensatory role in assisting with SRF gene
transcription. Due to limited sample availability, we
have not determined whether these kinases or alterna-
tive coactivators were upregulated in our model. Ele-
vated phosphorylated SRF levels in the older subjects
may reflect an attempt to maintain muscle size, cell
survival and muscle repair (Miano 2010). In relation
to the exercise intervention, a high basal SRF phos-
phorylation level in older subjects might be reflective
of an already maximal activation of the SRF protein
at rest, and therefore reduce the capacity for further
activation following an anabolic stress, such as resis-
tance exercise.
The regulation of members of the STARS pathway
in skeletal muscle is sensitive to the mechanical stress
induced by resistance exercise in untrained younger
subjects (MacNeil et al. 2010, Lamon et al. 2013,
Vissing et al. 2013), but its regulation in older sub-
jects has not been investigated. Here, we observed an
increase in the mRNA levels of members of the
STARS signalling pathway 2 h after an acute bout of
resistance exercise that was independent of age. Our
results revealed no changes in the protein levels of the
members of the STARS signalling pathway in response
to exercise. Any potential increase may possibly occur
later in the post-exercise recovery period. Indeed, two
recent studies from our group investigated the regula-
tion of the STARS signalling pathway following acute
exercise in trained and untrained young subjects
(Lamon et al. 2013, Vissing et al. 2013). In line with
the results of the present study, we only reported
minor changes in protein expression within the 3 h
following acute exercise (Vissing et al. 2013). The
early induction of STARS in response to resistance
exercise is believed to trigger intracellular signals
responsible for muscle adaptation to exercise; however
this has not yet been experimentally validated. While
the precise mechanisms involved are unknown, it has
been suggested (Arai et al. 2002, Lamon et al. 2013,
2014) that this adaptive response may protect against
contraction-induced muscle damage, in addition to
helping regeneration and repair, two processes that
are commonly disrupted in elderly subjects (Brack &
Rando 2007). Reduced basal levels of the STARS pro-
tein in older subjects may therefore reflect a reduced
capacity of STARS to protect the muscle following
exercise.
A limitation when recruiting community-dwelling
older subjects to participate in an exercise trial is that
they tend to be physically active and therefore not
necessarily representative of the average elderly popu-
lation. We have previously reported that the older
subject cohort used in this study was not considered
sarcopaenic (Zacharewicz et al. 2014). However, at
present, this study is the only one that has measured
and compared the regulation of the STARS signalling
pathway, at rest and following resistance exercise,
using an appropriately powered cohort of young and
older subjects. Discrepancies in observations made in
young and sarcopaenic mice (Sakuma et al. 2008) vs.
young and older men in the present study may be
imputable to species differences or to the fact that our
subjects were not sufficiently sarcopaenic. Therefore,
our findings might not be representative of a more
sedentary and/or sarcopaenic human population.
miRNAs are important regulators of skeletal muscle
health (Zacharewicz et al. 2013) that regulate gene
transcription by directly degrading mRNAs (Huili
et al. 2010), inhibiting protein translation (Lee et al.
2004a, Wightman et al. 2004, Humphreys et al.
2005, Pillai et al. 2005) and in some cases stabilizing
mRNAs (Vasudevan & Steitz 2007, Vasudevan et al.
2007, Ørom et al. 2008). The conditions and level of
specificity with which miRNAs interact with their
respective targets remain mostly unclear. Within the
scope of this study, we investigated the regulation of
the miRNAs known to target members of the STARS
signalling pathway. The expression levels of miR-320a
and miR-483-5p, two miRNAs negatively regulating
SRF transcription (Qiao et al. 2011, Chen et al.
2015), increased with age. MiR-483-5p is embedded
in the intron of the insulin-like growth factor 2 (IGF2)
gene and inhibits SRF mRNA and protein expression
by directly targeting the SRF transcript in endothelial
cells (Qiao et al. 2011). While SRF increased with
exercise in both subject groups, we observed a con-
comitant decrease in miR-483-5p levels, which
resulted in significant negative linear correlation. As
miR-483-5p directly binds to the SRF 3’UTR resulting
in its suppression (Qiao et al. 2011), the resistance
exercise-induced downregulation of miR-483-5p may
release its inhibition on SRF, therefore contributing to
the upregulation of the latter. Whether increased
STARS expression and attenuated miR-483-5p expres-
sion has an additive effect on SRF transcription would
© 2016 The Authors. Acta Physiologica published by John Wiley & Sons Ltd on behalf of
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be of interest to determine. Similarly, miR-320a can
also target the SRF transcript resulting in inhibition of
cell proliferation and promoting apoptosis in human-
derived endothelium cells (Chen et al. 2015). When
compared to healthy age-matched controls, miR-320a
is upregulated in several conditions associated with
skeletal muscle degeneration and atrophy, including
limb girdle muscular dystrophy type 2A, Miyoshi
myopathy, Nemaline myopathy, inclusion body myosi-
tis and polymyocytosis (Eisenberg et al. 2007). MiR-
320a is also known to play a role in energy metabo-
lism. It directly inhibits the rate-limiting step of gly-
colysis by targeting the enzyme phosphofructokinase
and its expression was reduced in C2C12 myotubes
and other biological systems when subjected to oxida-
tive stress (Tang et al. 2012). We have previously sug-
gested that STARS regulates energy metabolism in the
muscle fibre and have shown that STARS shifts the
muscle cell to a more oxidative phenotype (Wallace &
Russell 2013). Whether this process involves miR-
320a is unknown.
Of the three miRNAs predicted to target STARS,
miR-628-5p interacted with its putative binding
sequence on the STARS 3’UTR and repressed STARS
transcription in vitro. While mainly studied in cancer
models, it was suggested that miR-628-5p promotes
the expression of FOXO3a, a regulator of skeletal
muscle atrophy, in leukaemic progenitor cells in
response to IL-3 treatment (Favreau & Sathya-
narayana 2012), although no regulation of FOXO3a
gene or protein was observed in this cohort (Ste-
fanetti et al. 2015). The role and regulation of miR-
628-5p in skeletal muscle is relatively unknown. One
study has reported that miR-628-5p expression in
foetal skeletal muscle in human facioscapulohumeral
muscular dystrophy (FSHD) is upregulated at
14 weeks of foetal development but down regulated
at 22 weeks, when compared with age-matched con-
trols (Portilho et al. 2015). Whether miR-628-5p has
an acute effect on the regulation of STARS mRNA
post-exercise remains to be determined. Clearly more
studies are required to establish the precise role of
miR-628-5p in skeletal muscle growth, repair and
function over the lifespan.
In conclusion, we demonstrated that although the
resting levels of the STARS protein are lower in skeletal
muscle of older when compared to young subjects, this
did not affect the resistance exercise-induced upregula-
tion of STARS and SRFmRNA seen in both age groups.
These findings did not translate to the SRF protein,
which in addition displayed higher phosphorylation
levels in older than in young subjects. Finally, we identi-
fied for the first time that miR-628-5p is a resistance
exercise responsive miRNA that directly binds the
STARS 3’UTR to reduce its transcription in vitro.
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Physiological relevance
Striated muscle activator of Rho signalling (STARS) is
a molecular pathway that is essential to skeletal mus-
cle adaptation and function via the regulation of SRF
signalling. Here, we show for the first time that
STARS signalling is downregulated in older when
compared to younger human muscle, although STARS
regulation following an acute exercise bout is not age
dependent. In addition, we identify that miR-628-5p
is a resistance exercise responsive miRNA that directly
binds the STARS 3’UTR to reduce its transcription
in vitro.
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